[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100625984":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":28,"centralContacts":33,"locations":42,"responsibleParty":57,"collaborators":25,"id":60,"slug":25,"hasResults":61,"nctId":62,"briefTitle":63,"officialTitle":64,"acronym":25,"eligibilityCriteria":65,"healthyVolunteers":61,"sex":66,"minAge":67,"maxAge":25,"enrollmentInfo":68,"targetDuration":25,"studyType":71,"phases":72,"briefSummary":74,"conditions":75,"keywords":77,"overallStatus":84,"whyStopped":25,"lastUpdateSubmitDate":85,"lastUpdatePostDateStruct":86,"startDateStruct":89,"completionDateStruct":91,"leadSponsor":93,"locationsCount":94},{"fullName":5,"class":6},"Mansoura University","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Solifenacin Combined with Gabapentin","EXPERIMENTAL","using solifenacin combined with gabapentin for treatment of non-neurogenic overactive bladder in women",[13],"Drug: solifenacin combined with gabapentin",{"label":15,"type":16,"description":17,"interventionNames":18},"solifenacin monotherapy","SHAM_COMPARATOR","solifenacin monotherapy for treatment of non-neurogenic overactive bladder in women",[19],"Drug: solifenacin monotherapy",[21,26],{"type":22,"name":23,"description":11,"armGroupLabels":24,"otherNames":25},"DRUG","solifenacin combined with gabapentin",[9],null,{"type":22,"name":15,"description":17,"armGroupLabels":27,"otherNames":25},[15],[29],{"name":30,"affiliation":31,"role":32},"Urology and Nephrology center - Mansoura University","urology and nephrology center mansoura university","PRINCIPAL_INVESTIGATOR",[34,39],{"name":35,"role":36,"phone":37,"phoneExt":25,"email":38},"Mohamed Elmaghawry, Resident","CONTACT","+201125334957","m7md.gano2016@gmail.com",{"name":40,"role":36,"phone":25,"phoneExt":25,"email":41},"Mohamed Hegazy, Lecturer","hegazym912@gmail.com",[43],{"facility":30,"status":25,"city":44,"state":25,"zip":25,"country":45,"countryCode":46,"cosmosGeoPoint":47,"geoPoint":52,"contacts":53},"Al Mansurah","Egypt","EG",{"type":48,"coordinates":49},"Point",[50,51],31.38069,31.03637,{"lat":51,"lon":50},[54],{"name":30,"role":36,"phone":55,"phoneExt":25,"email":56},"+20502202222","unc@mans.edu.eg",{"type":32,"investigatorFullName":58,"investigatorTitle":59,"investigatorAffiliation":5,"oldNameTitle":25,"oldOrganization":25},"Mohammed Hegazy","lecturer of urology","100625984",false,"NCT07429734","Efficacy of Gabapentin Combined With Solifenacin for Non-neurogenic Overactive Bladder in Women","Efficacy and Tolerability of Solifenacin Combined With Gabapentin Versus Solifenacin Monotherapy for the Treatment of Non-neurogenic Overactive Bladder in Women: A Randomized Controlled Trial","Inclusion Criteria:\n\n* Overactive bladder symptom score (OABSS) \\> 5, urgency subscore ≥3, and urge incontinence score≥ 2.\n\nExclusion Criteria:\n\n* Active urinary tract infection\n* Neurogenic bladder\n* History of genitourinary malignancy\n* Stress urinary incontinence (SUI) as primary diagnosis, or mixed urinary incontinence with predominant SUI\n* Any psychological or psychiatric disorders","FEMALE","18 Years",{"count":69,"type":70},60,"ESTIMATED","INTERVENTIONAL",[73],"PHASE3","The goal of the study is to compare the efficacy, safety and tolerability of solifenacin plus gabapentin versus solifenacin monotherapy for the treatment of women who are suffering from non-neurogenic ОАВ.\n\nThe main questions it aims to answer are:\n\nDoes combination of Solifenacin and Gabapentin affect the total score and sub-scores of OABSS in females with non-neurogenic ОАВ ? What medical problems do participants have when taking combination of Solifenacin and gabapentin ?",[76],"Overactive Bladder",[78,79,80,81,82,83],"overactive bladder","non-neurogenic","gabapentin","solifenacin","anticholinergic","Randomized Controlled Trial","NOT_YET_RECRUITING","2026-02-23",{"date":87,"type":88},"2026-02-24","ACTUAL",{"date":90,"type":70},"2026-02",{"date":92,"type":70},"2027-01",{"name":5,"class":6},1]